Sunday, May 9, 2021

Pharma Reviews: India's second wave sees Covid drug FabiFlu sales jump 600% in April to rake in Rs 351 crore

... is now the top-selling brand in the pharma retail market of India, data shows. ... In March, FabiFlu registered sales of Rs 48.3 crore when India was ...
Read more: India's second wave sees Covid drug FabiFlu sales jump 600% in April to rake in Rs 351 crore